Last reviewed · How we verify
Norovirus Bivalent VLP Vaccine
Norovirus Bivalent VLP Vaccine is a Biologic drug developed by Takeda. It is currently in Phase 2 development.
At a glance
| Generic name | Norovirus Bivalent VLP Vaccine |
|---|---|
| Sponsor | Takeda |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Safety and Immunogenicity of HIL-214 in Healthy Japanese Infants (PHASE1)
- Long-Term Immunogenicity of the Norovirus GI.1/GII.4 Bivalent Virus-like Particle (VLP) Vaccine (NoV Vaccine) in Adults (PHASE2)
- Recombinant, Bivalent, Norovirus Vaccine Study (PHASE1)
- Efficacy and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-like Particle Vaccine in Adults (PHASE2)
- Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine in an Elderly Population (PHASE2)
- Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle (VLP) Vaccine in Children (PHASE2)
- Norovirus Bivalent-Vaccine Efficacy Study (PHASE1, PHASE2)
- Bivalent Norovirus Vaccine Study (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Norovirus Bivalent VLP Vaccine CI brief — competitive landscape report
- Norovirus Bivalent VLP Vaccine updates RSS · CI watch RSS
- Takeda portfolio CI
Frequently asked questions about Norovirus Bivalent VLP Vaccine
What is Norovirus Bivalent VLP Vaccine?
Norovirus Bivalent VLP Vaccine is a Biologic drug developed by Takeda.
Who makes Norovirus Bivalent VLP Vaccine?
Norovirus Bivalent VLP Vaccine is developed by Takeda (see full Takeda pipeline at /company/takeda).
What development phase is Norovirus Bivalent VLP Vaccine in?
Norovirus Bivalent VLP Vaccine is in Phase 2.
Related
- Manufacturer: Takeda — full pipeline
- Compare: Norovirus Bivalent VLP Vaccine vs similar drugs
- Pricing: Norovirus Bivalent VLP Vaccine cost, discount & access